Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | BTK | Q06187 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19668082 | 0.90 | LPL (0.38) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL59040 | 0.84 | LPL (0.37) | LPLLIPGJAK2BTK | |
| SCHEMBL15289502 | 0.84 | LPL (0.37) | LPLLIPGJAK2BTK | |
| SCHEMBL29385065 | 0.84 | LPL (0.37) | LPLLIPGJAK2BTK | |
| SCHEMBL21067074 | 0.81 | CYP3A4 (0.35) | LPLLIPGJAK2BTK | |
| SCHEMBL30316458 | 0.81 | CYP3A4 (0.35) | LPLLIPGJAK2BTK | |
| SCHEMBL30935317 | 0.81 | CYP3A4 (0.35) | LPLLIPGJAK2BTK | |
| SCHEMBL24457822 | 0.81 | CYP3A4 (0.35) | LPLLIPGJAK2BTK | |
| SCHEMBL25277938 | 0.80 | GAA (0.35) | LPLLIPGJAK2BTK | |
| SCHEMBL21067071 | 0.80 | GAA (0.35) | LPLLIPGJAK2BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4134098-A1 | METHOD OF CANCER THERAPY | ONO Pharmaceutical Co., Ltd. (JP) | 2023-02-15 | — | — | EP | disclosed |